Charles River Laboratories Inte EPS (Earnings per Share) 2008–2025
Charles River Laboratories Inte reported $-2.91 of earnings per share for fiscal 2025. That was 1555.0% lower than fiscal 2024. Compared with fiscal 2020, the change was -140.4%.
| Fiscal year | EPS (Earnings per Share) | Change (YoY) |
|---|---|---|
| FY 2025 | $-2.91 | -1555.0% |
| FY 2024 | $0.20 | -97.8% |
| FY 2023 | $9.22 | -2.7% |
| FY 2022 | $9.48 | +24.7% |
| FY 2021 | $7.60 | +5.6% |
| FY 2020 | $7.20 | +42.0% |
| FY 2019 | $5.07 | +9.7% |
| FY 2018 | $4.62 | +81.9% |
| FY 2017 | $2.54 | -21.4% |
| FY 2016 | $3.23 | +3.2% |
| FY 2015 | $3.13 | +17.7% |
| FY 2014 | $2.66 | +25.5% |
| FY 2013 | $2.12 | +5.5% |
| FY 2012 | $2.01 | -6.1% |
| FY 2011 | $2.14 | +139.8% |
| FY 2010 | $-5.38 | -409.2% |
| FY 2009 | $1.74 | +122.3% |
| FY 2008 | $-7.80 | — |
Source: Charles River Laboratories Inte SEC filings — income statement (10-K), split-adjusted. Computed deterministically; refreshed nightly (last updated August 2, 2026). Open CRL 10-K filings at SEC EDGAR · Methodology · Download CSV.
How to read this history
Charles River Laboratories Inte reported $-2.91 of earnings per share for fiscal 2025. That was 1555.0% lower than fiscal 2024. Compared with fiscal 2020, the change was -140.4%. Values remain missing when the cached filing does not disclose a comparable line item; they are never estimated. Stock splits, reorganizations and fiscal-calendar changes can reduce comparability.
Prepared and reviewed by the stockportfolio.pro research desk. Corrections: support@stockportfolio.pro.
See the full picture for Charles River Laboratories Inte
Complete income statement, balance sheet and cash flow with trend on every row, 48 quarters, ratios, health checks, and Ask — the SEC-grounded research assistant.
Open the interactive view — freeCharles River Laboratories Inte — frequently asked questions
What is Charles River Laboratories Inte's earnings per share?
Charles River Laboratories Inte (CRL) reported earnings per share of $-2.91 for fiscal year 2025, per its SEC filings.
Where does this data come from?
Figures are computed from Charles River Laboratories Inte's official SEC filings (income statement (10-K), split-adjusted), refreshed nightly. Not investment advice.